Skip to main content
OpenTrials

Clinical trial condition

Pulmonary Disease, Chronic Obstructive

Explore clinical trials studying Pulmonary Disease, Chronic Obstructive. Study availability and eligibility vary by location and protocol.

787 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Pulmonary Disease, Chronic Obstructive trial results

Completed

Validation of a New Shortness of Breath With Daily Activities Questionnaire in Patients With Chronic Obstructive Pulmonary Disease

NCT00984659

Conditions
Chronic Disease, Disease Attributes, Dyspnea, +9 more
Locations
  • GSK Investigational Site Jasper, Alabama, United States
  • GSK Investigational Site Mobile, Alabama, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Riverside, California, United States
View all 39 locations
View Trial Details
Completed

Efficacy and Safety of Mepolizumab as an Add-on Treatment in Chronic Obstructive Pulmonary Disease (COPD)

NCT02105961

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Mobile, Alabama, United States
  • GSK Investigational Site Riverside, California, United States
  • GSK Investigational Site Upland, California, United States
View all 169 locations
View Trial Details
Completed

A Study to Evaluate the Effect of the Combination of Umeclidinium (UMEC) and Vilanterol (VI) on Exercise Endurance Time (EET) in Participants With Chronic Obstructive Pulmonary Disease (COPD)

NCT02275052

Conditions
Behavior, Chronic Disease, Disease Attributes, +7 more
Locations
  • GSK Investigational Site Jasper, Alabama, United States
  • GSK Investigational Site Saint Charles, Missouri, United States
  • GSK Investigational Site Charlotte, North Carolina, United States
  • GSK Investigational Site Medford, Oregon, United States
View Trial Details
Completed

Safety and Efficacy Study of Losmapimod (GW856553) in Frequently Exacerbating Participants With Chronic Obstructive Pulmonary Disease (COPD)

NCT02299375

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Buenos Aires, Argentina
  • GSK Investigational Site Mendoza, Argentina
  • GSK Investigational Site Mendoza, Argentina
  • GSK Investigational Site San Miguel de Tucumán, Argentina
View all 36 locations
View Trial Details
Completed

Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease

NCT01313676

Conditions
Cardiovascular Diseases, Chronic Disease, Disease Attributes, +6 more
Locations
  • GSK Investigational Site Andalusia, Alabama, United States
  • GSK Investigational Site Athens, Alabama, United States
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Birmingham, Alabama, United States
View all 1611 locations
View Trial Details
Completed

A 24-week Evaluation of GSK573719/Vilanterol (62.5/25mcg) and Components in COPD

NCT01313650

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Ormond Beach, Florida, United States
  • GSK Investigational Site Tampa, Florida, United States
View all 165 locations
View Trial Details

Related conditions